secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vera Therapeutics, Inc. (VERA)
CIK:        0001831828
Form:       8-K
Filed at:   2021-07-14T23:59:59+00:00
Accession:  0001193125-21-215234
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vera Therapeutics appoints Sean P. Grant as CFO; Jonathan Wolter resigns
------------------------------------------------------------------------

- Sean P. Grant named CFO effective July 12, 2021; annual base salary $400,000.
- Grant receives option to purchase 180,000 shares vesting over 4 years.
- Previous CFO Jonathan Wolter resigned effective July 14, 2021; no disagreement cited.
- Grant previously VP of Corporate Strategy at CareDx and VP in Citigroup Healthcare Investment Banking.
- Employment letter includes severance of 9 months salary (12 months on change in control).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831828/000119312521215234/0001193125-21-215234-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831828/000119312521215234/d185242d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-215234

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer